Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population

This 2021 observational study published in the European Journal of Preventive Cardiology (DOI: 10.1177/2047487319885458) examined the link between modifiable lifestyle risk factors (modRFs) and systemic inflammation, measured via high-sensitivity C-reactive protein (hsCRP), in 1,014 patients with coronary artery disease (CAD). Nearly half of the patients had elevated hsCRP levels (≥2